Thanks to this session, aimed at revealing the exceptional performance of Evolut PRO+, learn key considerations for patients with longer life expectancy and explore the pathway to a single-digit pacemaker post-TAVI.

Find out more about an 87-year-old male patient with PCI mid-LAD with BMS 9/1998, several risk factors, preserved LVEF and eGFR, symptomatic with unstable angina, and on medical therapy...

In this session, learn about the TricValve system in the treatment of severe TR and right heart disease, obtain insight from the experts with case scenarios, and understand how the TricValve Transcatheter Bicavel system can help patients with severe TR.

How did one coronary lesion become three lesions by OCT?

This session will enable you to discuss the clinical outcomes of TAVI results in patients with small aortic annuli, learn how to best measure and assess gradients when performing TAVI, and review a case of a patient with small annuli treated with TAVI.

In this session on percutaneous coronary intervention, learn about available physiology tools for a full coronary assessment, understand how OCT impacts decision-making to strategise and optimise PCI, and learn through case examples how the use of physiology and OCT impacts daily practice.

A 70-year-old male patient was referred to hospital with signs of acute myocardial infarction. Echocardiography confirmed impaired left ventricular function and severe low flow, low gradient aortic valve stenosis. Would you go for surgical aortic valve replacement or transfemoral TAVI?

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.

Elad Asher provides his take on this phase IIb trial in healthy people ages 50 to 80 showing that the novel intravenous treatment bentracimab significantly restored platelet function in patients receiving oral P2Y12 inhibitor ticagrelor. The clinical trial was presented by Deepak L. Bhatt at the American College of Cardiology...

In this interview, Mirvat Alasnag asks Shamir R. Mehta about the results of a prespecified analysis of the COMPLETE study which he presented during the ACC 2022 Scientific sessions. 

Luis Ortega-Paz interviews Frederik Zimmermann, first co-author of the FAME 3 Trial which he presented during the American College of Cardiology’s annual scientific sessions. The trial was published simultaneously in the journal Circulation.

Find out more about a 77-year-old male patient with hypertension without good BP control, dyslipidaemia, Type II-DM, ex-smoker, who had triple CABG in 2006, EF 60% in 2017, and presented with dyspnea. 

Dejan Milasinovic provides his take on the EDIT-CMD Randomized Clinical Trial which aimed to assess the efficacy of diltiazem to improve coronary vasomotor dysfunction in angina and nonobstructive coronary arteries.

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Michele Pighi provides his take on the National Cardiovascular LAAO Registry that analyzed data from 51,333 patients who underwent LAAO procedures with the WATCHMAN device between 2016-2019, as part of the College's NCDR registries.

An 89-year-old man was referred for treatment of severe symptomatic aortic stenosis. This case describes the decision-making in performing TAVI in a patient with twin challenges of small annulus and significant LVOT calcification.

Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.